Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
NCT ID: NCT05900687
Last Updated: 2023-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
150 participants
INTERVENTIONAL
2023-07-01
2028-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decision Aid for Gastroesophageal Reflux Disease Management
NCT01641887
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
NCT00260572
Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life
NCT01536080
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
NCT00914342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focus Group (Aim 1)
Participants give feedback about day-to-day challenges with GERD.
No interventions assigned to this group
Focus Group (Aim 2)
Participants give feedback about mobile health app prototype
No interventions assigned to this group
mHealth app (Aim 3)
Participants will be exposed to an app-based question prompt list with gamification features to promote medication adherence as part of their communication with their health provider.
Use of mHealth Question Prompt List app
mHealth Question Prompt List app that facilitates in asking questions with a physician during a consultation specific to GERD
Standard of care (Aim 3)
Participants will be exposed to standard of care communication with their health provider (no mHealth app).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of mHealth Question Prompt List app
mHealth Question Prompt List app that facilitates in asking questions with a physician during a consultation specific to GERD
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GerdQ score of \>=8
* documented PPI use for GERD
* internet access at home or computer/mobile device
* ability to provide written or e-consent.
Exclusion Criteria
* non-English speaking patients
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Afrin Kamal
Clinical Assistant Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Afrin N Kamal, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
62297
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.